Robert Burns
Stock Analyst at HC Wainwright & Co.
(3.76)
# 702
Out of 5,182 analysts
502
Total ratings
43.57%
Success rate
9.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $25 | $8.91 | +180.58% | 29 | Apr 2, 2026 | |
| BNTX BioNTech SE | Maintains: Buy | $140 → $130 | $91.28 | +42.42% | 47 | Mar 31, 2026 | |
| AKTS Aktis Oncology | Maintains: Buy | $30 → $33 | $16.37 | +101.59% | 2 | Mar 31, 2026 | |
| BCAX Bicara Therapeutics | Maintains: Buy | $40 → $42 | $20.85 | +101.44% | 6 | Mar 31, 2026 | |
| IMMX Immix Biopharma | Reiterates: Buy | $15 | $8.59 | +74.62% | 12 | Mar 30, 2026 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $48 → $56 | $38.94 | +43.81% | 6 | Mar 26, 2026 | |
| KPTI Karyopharm Therapeutics | Maintains: Buy | $15 → $8 | $6.32 | +26.58% | 5 | Mar 25, 2026 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $32 | $15.79 | +102.66% | 22 | Mar 24, 2026 | |
| ACET Adicet Bio | Maintains: Buy | $50 → $27 | $6.90 | +291.30% | 4 | Mar 23, 2026 | |
| RLAY Relay Therapeutics | Maintains: Buy | $14 → $19 | $12.45 | +52.61% | 23 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.67 | +117.98% | 23 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $13 | $4.38 | +196.80% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $27 | $4.35 | +520.69% | 5 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.04 | +221.78% | 3 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $17 | $10.67 | +59.33% | 9 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.93 | +41.99% | 2 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $44 | $24.97 | +76.21% | 12 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $29 | $8.91 | +225.48% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $27 | $20.29 | +33.07% | 13 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $46 | $25.84 | +78.02% | 24 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $54 | $43.98 | +22.78% | 15 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.45 | +589.66% | 5 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.58 | +532.91% | 4 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $9.09 | +120.02% | 4 | Jan 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $17 | $4.45 | +282.02% | 18 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $14.92 | +80.97% | 4 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $52 | $35.42 | +46.81% | 16 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $95.36 | -23.45% | 21 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $9 | $1.95 | +361.54% | 15 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $2 | $3.18 | -37.11% | 22 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.19 | +320.17% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $8.54 | +40.52% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.68 | +35.87% | 17 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $2.50 | +300.00% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.30 | +284.62% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $2.60 | +207.69% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.87 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $14.00 | +1,328.57% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $0.24 | +97,899.18% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.45 | +33,607.87% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $4.40 | +150.00% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $1.68 | +2,678,471.43% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.39 | +835.25% | 1 | Jan 7, 2021 |
ORIC Pharmaceuticals
Apr 2, 2026
Reiterates: Buy
Price Target: $25
Current: $8.91
Upside: +180.58%
BioNTech SE
Mar 31, 2026
Maintains: Buy
Price Target: $140 → $130
Current: $91.28
Upside: +42.42%
Aktis Oncology
Mar 31, 2026
Maintains: Buy
Price Target: $30 → $33
Current: $16.37
Upside: +101.59%
Bicara Therapeutics
Mar 31, 2026
Maintains: Buy
Price Target: $40 → $42
Current: $20.85
Upside: +101.44%
Immix Biopharma
Mar 30, 2026
Reiterates: Buy
Price Target: $15
Current: $8.59
Upside: +74.62%
Enliven Therapeutics
Mar 26, 2026
Maintains: Buy
Price Target: $48 → $56
Current: $38.94
Upside: +43.81%
Karyopharm Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $15 → $8
Current: $6.32
Upside: +26.58%
Nurix Therapeutics
Mar 24, 2026
Reiterates: Buy
Price Target: $32
Current: $15.79
Upside: +102.66%
Adicet Bio
Mar 23, 2026
Maintains: Buy
Price Target: $50 → $27
Current: $6.90
Upside: +291.30%
Relay Therapeutics
Mar 23, 2026
Maintains: Buy
Price Target: $14 → $19
Current: $12.45
Upside: +52.61%
Mar 23, 2026
Maintains: Buy
Price Target: $7 → $8
Current: $3.67
Upside: +117.98%
Mar 23, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $4.38
Upside: +196.80%
Mar 16, 2026
Maintains: Buy
Price Target: $34 → $27
Current: $4.35
Upside: +520.69%
Mar 16, 2026
Reiterates: Buy
Price Target: $13
Current: $4.04
Upside: +221.78%
Mar 13, 2026
Maintains: Buy
Price Target: $13 → $17
Current: $10.67
Upside: +59.33%
Mar 13, 2026
Reiterates: Buy
Price Target: $7
Current: $4.93
Upside: +41.99%
Mar 6, 2026
Maintains: Buy
Price Target: $42 → $44
Current: $24.97
Upside: +76.21%
Mar 6, 2026
Maintains: Buy
Price Target: $27 → $29
Current: $8.91
Upside: +225.48%
Mar 6, 2026
Maintains: Buy
Price Target: $13 → $27
Current: $20.29
Upside: +33.07%
Mar 6, 2026
Maintains: Buy
Price Target: $32 → $46
Current: $25.84
Upside: +78.02%
Feb 12, 2026
Maintains: Buy
Price Target: $52 → $54
Current: $43.98
Upside: +22.78%
Feb 3, 2026
Reiterates: Buy
Price Target: $10
Current: $1.45
Upside: +589.66%
Jan 28, 2026
Reiterates: Buy
Price Target: $10
Current: $1.58
Upside: +532.91%
Jan 21, 2026
Reiterates: Buy
Price Target: $20
Current: $9.09
Upside: +120.02%
Jan 12, 2026
Maintains: Buy
Price Target: $18 → $17
Current: $4.45
Upside: +282.02%
Jan 8, 2026
Maintains: Buy
Price Target: $26 → $27
Current: $14.92
Upside: +80.97%
Jan 6, 2026
Maintains: Buy
Price Target: $50 → $52
Current: $35.42
Upside: +46.81%
Nov 6, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $95.36
Upside: -23.45%
Nov 5, 2025
Maintains: Buy
Price Target: $3 → $9
Current: $1.95
Upside: +361.54%
Nov 3, 2025
Reiterates: Neutral
Price Target: $2
Current: $3.18
Upside: -37.11%
Oct 31, 2025
Upgrades: Buy
Price Target: $5
Current: $1.19
Upside: +320.17%
Oct 27, 2025
Upgrades: Buy
Price Target: $12
Current: $8.54
Upside: +40.52%
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $3.68
Upside: +35.87%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.50
Upside: +300.00%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.30
Upside: +284.62%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $2.60
Upside: +207.69%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.87
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $14.00
Upside: +1,328.57%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $0.24
Upside: +97,899.18%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.45
Upside: +33,607.87%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $4.40
Upside: +150.00%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $1.68
Upside: +2,678,471.43%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.39
Upside: +835.25%